Clinical Trial


An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis


Brief description

The purpose of this study is to evaluate the efficacy of ontamalimab as maintenance therapy treatment of remission, based on composite score of patient-reported symptoms and centrally read endoscopy, in participants with moderate to severe ulcerative colitis (UC).

Keywords

  •   Ulcerative Colitis

Sponsored By

Shire

Unique Study ID

NCT03290781

Investigators and Research Sites Near You - Found( 3 )

No Investigator Listed

R-Pharm
85210, Mesa, Arizona, United States
Distance from Current Trial is 0 miles

No Investigator Listed

Bayer
85210, Mesa, Arizona, United States
Distance from Current Trial is 0 miles

No Investigator Listed

Bayer
85209, Mesa, Arizona, United States
Distance from Current Trial is 0 miles
View All